Door to Puncture in Large Vessel Occlusions Pre‐ and Postimplementation of an Automated Image Interpretation and Communication Platform: A Single Center Study

Author:

Frost Emma1,Penckofer Mary2,Zhang Linda2,Sprankle Kenyon2,Vigilante Nicholas2,Elgendy Omnea2,Ackerman Jiyoun2,Kalladanthyil Abyson2,Koneru Manisha2,Yi Zixin2,Khalife Jane1,Hester Taryn1,Schumacher Hermann Christian1,Bonner James3,Love Christopher J.4,Siegler James E.15ORCID

Affiliation:

1. Cooper Neurological Institute Cooper University Hospital Camden NJ

2. Cooper Medical School of Rowan University Camden NJ

3. Inspira Medical Center Mullica Hill NJ

4. Viz.ai San Francisco CA

5. Department of Neurology University of Chicago Chicago IL

Abstract

Background Artificial intelligence platforms, like Viz.ai with large vessel occlusion detection, have been used for disease detection and interprovider communication. Whether this software expedites patient transfer and evaluation for treatment needs further exploration. Methods A single‐center retrospective registry was queried for patients with acute large vessel occlusion of the intracranial internal carotid, middle cerebral M1 or M2 segments, or basilar artery treated in a comprehensive stroke network (8 spokes, 1 hub) for 6 months pre‐ and post‐implementation of the Viz large vessel occlusion platform (excluding a 1‐month “washout” period). Robust regression was used to summarize time from initial hospital contact to arterial puncture (primary outcome) between periods, with prespecified subgroup analyses, which were assessed using interaction terms. Results Of the 132 patients (n = 58 preintervention), there were nonsignificantly fewer patients undergoing endovascular therapy in the postintervention period (86.2% preintervention versus 73.0% postintervention; P  = 0.07). Among patients who underwent endovascular therapy (n = 50 preintervention, n = 54 postintervention), there was a nonsignificant reduction in time from first contact to arterial puncture (median 155 minute preintervention versus 116 minute postintervention; P  = 0.10); however, this became significant in adjusted robust regression accounting for stroke severity, age, Alberta Stroke Program Early Computed Tomography Scale score, daytime versus nighttime and weekend versus weekday arrival, and use of perfusion imaging (β −20.9 [95% CI, −40.5 to −1.4)]. There was also a significant interaction observed for the association between spoke versus hub arrival and the Viz large vessel occlusion period, with shorter intervals observed for transferred patients (n = 32 preintervention with a median of 169 versus 142 minutes for n = 33 postintervention; P interaction <0.01). Conclusion Implementation of the artificial intelligence platform was not associated with shorter intervals between initial hospital contact and neurointervention among all‐comers. A meaningful difference in time to treatment was observed among transferred patients. Larger data sets are needed to validate these observations.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference17 articles.

1. Endovascular therapy for ischemic stroke

2. Office of the Commissioner . FDA Permits Marketing of Clinical Decision Support Software for Alerting Providers of a Potential Stroke in Patients. U.S. Food and Drug Administration; 2020. [cited 2024 January, 15]. https://www.fda.gov/news‐events/press‐announcements/fda‐permits‐marketing‐clinical‐decision‐support‐software‐alerting‐providers‐potential‐stroke

3. FDA approves stroke‐detecting AI software;Nat Biotechnol,2018

4. The hub‐and‐spoke organization design revisited: a lifeline for rural hospitals;Elrod JK;BMC Health Serv Res,2017

5. Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3